Logo image of CMA

COMERICA INC (CMA) Stock Fundamental Analysis

NYSE:CMA - US2003401070 - Common Stock

70.58 USD
-0.24 (-0.34%)
Last: 8/29/2025, 8:13:46 PM
70.58 USD
0 (0%)
After Hours: 8/29/2025, 8:13:46 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CMA. CMA was compared to 395 industry peers in the Banks industry. CMA may be in some trouble as it scores bad on both profitability and health. CMA has a valuation in line with the averages, but it does not seem to be growing. CMA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CMA had positive earnings in the past year.
CMA had a positive operating cash flow in the past year.
In the past 5 years CMA has always been profitable.
In the past 5 years CMA always reported a positive cash flow from operatings.
CMA Yearly Net Income VS EBIT VS OCF VS FCFCMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.89%, CMA is in line with its industry, outperforming 52.02% of the companies in the same industry.
CMA has a Return On Equity of 10.09%. This is in the better half of the industry: CMA outperforms 66.92% of its industry peers.
Industry RankSector Rank
ROA 0.89%
ROE 10.09%
ROIC N/A
ROA(3y)1.05%
ROA(5y)0.98%
ROE(3y)15.08%
ROE(5y)13.13%
ROIC(3y)N/A
ROIC(5y)N/A
CMA Yearly ROA, ROE, ROICCMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 20.88%, CMA is doing worse than 61.62% of the companies in the same industry.
In the last couple of years the Profit Margin of CMA has declined.
CMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 20.88%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-18.65%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
CMA Yearly Profit, Operating, Gross MarginsCMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

CMA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CMA has been reduced compared to 1 year ago.
The number of shares outstanding for CMA has been reduced compared to 5 years ago.
CMA has a worse debt/assets ratio than last year.
CMA Yearly Shares OutstandingCMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CMA Yearly Total Debt VS Total AssetsCMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

CMA has a debt to FCF ratio of 2.06. This is a good value and a sign of high solvency as CMA would need 2.06 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.06, CMA is in line with its industry, outperforming 48.48% of the companies in the same industry.
CMA has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, CMA is not doing good in the industry: 74.24% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for CMA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.06
Altman-Z N/A
ROIC/WACCN/A
WACC13.85%
CMA Yearly LT Debt VS Equity VS FCFCMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CMA Yearly Current Assets VS Current LiabilitesCMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CMA have decreased strongly by -11.84% in the last year.
Measured over the past years, CMA shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.99% on average per year.
Looking at the last year, CMA shows a small growth in Revenue. The Revenue has grown by 0.85% in the last year.
Measured over the past years, CMA shows a decrease in Revenue. The Revenue has been decreasing by -0.64% on average per year.
EPS 1Y (TTM)-11.84%
EPS 3Y-13.01%
EPS 5Y-6.99%
EPS Q2Q%-4.7%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y3.02%
Revenue growth 5Y-0.64%
Sales Q2Q%3.03%

3.2 Future

CMA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.31% yearly.
Based on estimates for the next years, CMA will show a small growth in Revenue. The Revenue will grow by 1.52% on average per year.
EPS Next Y-3.19%
EPS Next 2Y2.19%
EPS Next 3Y4.38%
EPS Next 5Y1.31%
Revenue Next Year3.05%
Revenue Next 2Y3.04%
Revenue Next 3Y2.86%
Revenue Next 5Y1.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMA Yearly Revenue VS EstimatesCMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CMA Yearly EPS VS EstimatesCMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.17, CMA is valued correctly.
CMA's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CMA to the average of the S&P500 Index (27.13), we can say CMA is valued rather cheaply.
CMA is valuated correctly with a Price/Forward Earnings ratio of 12.36.
CMA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CMA is more expensive than 66.92% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CMA to the average of the S&P500 Index (22.76), we can say CMA is valued slightly cheaper.
Industry RankSector Rank
PE 13.17
Fwd PE 12.36
CMA Price Earnings VS Forward Price EarningsCMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CMA is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.76
EV/EBITDA N/A
CMA Per share dataCMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.19%
EPS Next 3Y4.38%

7

5. Dividend

5.1 Amount

CMA has a Yearly Dividend Yield of 4.01%, which is a nice return.
Compared to an average industry Dividend Yield of 3.17, CMA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, CMA pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.01%

5.2 History

The dividend of CMA has a limited annual growth rate of 2.70%.
CMA has been paying a dividend for at least 10 years, so it has a reliable track record.
CMA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.7%
Div Incr Years0
Div Non Decr Years7
CMA Yearly Dividends per shareCMA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CMA pays out 57.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
CMA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.8%
EPS Next 2Y2.19%
EPS Next 3Y4.38%
CMA Yearly Income VS Free CF VS DividendCMA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CMA Dividend Payout.CMA Dividend Payout, showing the Payout Ratio.CMA Dividend Payout.PayoutRetained Earnings

COMERICA INC

NYSE:CMA (8/29/2025, 8:13:46 PM)

After market: 70.58 0 (0%)

70.58

-0.24 (-0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-18 2025-07-18/bmo
Earnings (Next)10-17 2025-10-17/bmo
Inst Owners91.74%
Inst Owner Change-1.39%
Ins Owners0.82%
Ins Owner Change-0.21%
Market Cap9.07B
Analysts52.41
Price Target68.04 (-3.6%)
Short Float %6.24%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 4.01%
Yearly Dividend3.04
Dividend Growth(5Y)2.7%
DP57.8%
Div Incr Years0
Div Non Decr Years7
Ex-Date09-15 2025-09-15 (0.71)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)9.73%
Max EPS beat(2)13.02%
EPS beat(4)4
Avg EPS beat(4)10.26%
Min EPS beat(4)5.23%
Max EPS beat(4)13.07%
EPS beat(8)8
Avg EPS beat(8)11.56%
EPS beat(12)12
Avg EPS beat(12)8.6%
EPS beat(16)15
Avg EPS beat(16)7.93%
Revenue beat(2)0
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-1.27%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-1.34%
Max Revenue beat(4)-0.18%
Revenue beat(8)2
Avg Revenue beat(8)-1.76%
Revenue beat(12)6
Avg Revenue beat(12)-0.83%
Revenue beat(16)9
Avg Revenue beat(16)-0.61%
PT rev (1m)9.25%
PT rev (3m)11.24%
EPS NQ rev (1m)-1.42%
EPS NQ rev (3m)-7.32%
EPS NY rev (1m)0.32%
EPS NY rev (3m)0.63%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-2.52%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE 13.17
Fwd PE 12.36
P/S 2.74
P/FCF 6.76
P/OCF 6.28
P/B 1.32
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)5.36
EY7.59%
EPS(NY)5.71
Fwd EY8.09%
FCF(TTM)10.43
FCFY14.78%
OCF(TTM)11.23
OCFY15.92%
SpS25.78
BVpS53.37
TBVpS53.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 10.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.88%
GM N/A
FCFM 40.46%
ROA(3y)1.05%
ROA(5y)0.98%
ROE(3y)15.08%
ROE(5y)13.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-18.65%
PM growth 5Y-10.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.06
Debt/EBITDA N/A
Cap/Depr 104.04%
Cap/Sales 3.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 193.79%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC13.85%
ROIC/WACCN/A
Cap/Depr(3y)141.46%
Cap/Depr(5y)113.65%
Cap/Sales(3y)3.77%
Cap/Sales(5y)3.27%
Profit Quality(3y)81.63%
Profit Quality(5y)94.1%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.84%
EPS 3Y-13.01%
EPS 5Y-6.99%
EPS Q2Q%-4.7%
EPS Next Y-3.19%
EPS Next 2Y2.19%
EPS Next 3Y4.38%
EPS Next 5Y1.31%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y3.02%
Revenue growth 5Y-0.64%
Sales Q2Q%3.03%
Revenue Next Year3.05%
Revenue Next 2Y3.04%
Revenue Next 3Y2.86%
Revenue Next 5Y1.52%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.56%
FCF growth 3Y-7.39%
FCF growth 5Y-14.9%
OCF growth 1Y11.33%
OCF growth 3Y-1.77%
OCF growth 5Y-11.23%